Literature DB >> 21123412

Association of general medical and psychiatric comorbidities with receipt of guideline-concordant care for depression.

Susan L Ettner1, Francisca Azocar, Robert B Branstrom, Lisa S Meredith, Lily Zhang, Michael K Ong.   

Abstract

OBJECTIVE: This study described the association of general medical and psychiatric comorbidities with receipt of guideline-concordant depression care.
METHODS: Pharmacy, medical, and behavioral claims and enrollment data from OptumHealth in 2003-2006 were linked for 1,835 adults with a new depression diagnosis or a new antidepressant fill. Multiple logistic regression was used to estimate the association of comorbidities with receipt of guideline-concordant pharmacotherapy, guideline-concordant psychotherapy, and any guideline-concordant therapy.
RESULTS: Eleven percent of patients received guideline-concordant psychotherapy; 23%, guideline-concordant pharmacotherapy; and 33%, any guideline-concordant therapy. Having a psychiatric but no medical comorbidity was associated with higher rates of guideline-concordant psychotherapy and overall guideline concordance; conversely, having a general medical but no psychiatric comorbidity was associated with lower rates of guideline-concordant psychotherapy. Comorbidities were associated with the probability of receiving any guideline-concordant therapy, but they were not associated with improved guideline concordance among patients already receiving therapy.
CONCLUSIONS: Patients with general medical comorbidities may not receive psychotherapy referrals, perhaps because of well-established relationships with their primary care providers.

Entities:  

Mesh:

Year:  2010        PMID: 21123412      PMCID: PMC3776027          DOI: 10.1176/ps.2010.61.12.1255

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  22 in total

1.  The relationship between quality and outcomes in routine depression care.

Authors:  J Fortney; K Rost; M Zhang; J Pyne
Journal:  Psychiatr Serv       Date:  2001-01       Impact factor: 3.084

2.  The validity of self-reported physician utilization measures.

Authors:  P D Cleary; A M Jette
Journal:  Med Care       Date:  1984-09       Impact factor: 2.983

3.  Interventions to improve provider diagnosis and treatment of mental disorders in primary care. A critical review of the literature.

Authors:  K Kroenke; A Taylor-Vaisey; A J Dietrich; T E Oxman
Journal:  Psychosomatics       Date:  2000 Jan-Feb       Impact factor: 2.386

4.  Competing demands from physical problems: effect on initiating and completing depression care over 6 months.

Authors:  P A Nutting; K Rost; J Smith; J J Werner; C Elliot
Journal:  Arch Fam Med       Date:  2000 Nov-Dec

5.  Recent care of common mental disorders in the United States : prevalence and conformance with evidence-based recommendations.

Authors:  P S Wang; P Berglund; R C Kessler
Journal:  J Gen Intern Med       Date:  2000-05       Impact factor: 5.128

6.  The role of competing demands in the treatment provided primary care patients with major depression.

Authors:  K Rost; P Nutting; J Smith; J C Coyne; L Cooper-Patrick; L Rubenstein
Journal:  Arch Fam Med       Date:  2000-02

7.  Collaborative management to achieve treatment guidelines. Impact on depression in primary care.

Authors:  W Katon; M Von Korff; E Lin; E Walker; G E Simon; T Bush; P Robinson; J Russo
Journal:  JAMA       Date:  1995-04-05       Impact factor: 56.272

Review 8.  Combined pharmacotherapy and psychological treatment for depression: a systematic review.

Authors:  Sandro Pampallona; Paola Bollini; Giuseppe Tibaldi; Bruce Kupelnick; Carmine Munizza
Journal:  Arch Gen Psychiatry       Date:  2004-07

9.  Improving the care for depression in patients with comorbid medical illness.

Authors:  Alan K Koike; Jürgen Unützer; Kenneth B Wells
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

10.  Psychiatric consultation in the family physician's office. Advantages and hidden benefits.

Authors:  N Kates
Journal:  Gen Hosp Psychiatry       Date:  1988-11       Impact factor: 3.238

View more
  8 in total

1.  Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.

Authors:  Michael K Ong; Haiyong Xu; Lily Zhang; Francisca Azocar; Susan L Ettner
Journal:  J Am Geriatr Soc       Date:  2012-06-21       Impact factor: 5.562

Review 2.  Strategies to improve the management of depression in primary care.

Authors:  Jürgen Unützer; Mijung Park
Journal:  Prim Care       Date:  2012-06       Impact factor: 2.907

3.  Quality of depression treatment in Black Americans with major depression and comorbid medical illness.

Authors:  Amma A Agyemang; Briana Mezuk; Paul Perrin; Bruce Rybarczyk
Journal:  Gen Hosp Psychiatry       Date:  2014-03-07       Impact factor: 3.238

4.  Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders.

Authors:  María Del Mar Alañón Pardo; Mónica Ferrit Martín; Miguel Ángel Calleja Hernández; Francisco Morillas Márquez
Journal:  Eur J Clin Pharmacol       Date:  2017-06-26       Impact factor: 2.953

5.  Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders.

Authors:  Michael K Ong; Lily Zhang; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2012-07       Impact factor: 3.084

6.  Duration of medical home participation and quality of care for patients with chronic conditions.

Authors:  Karen E Swietek; Marisa Elena Domino; Lexie R Grove; Chris Beadles; Alan R Ellis; Joel F Farley; Carlos Jackson; Jesse C Lichstein; C Annette DuBard
Journal:  Health Serv Res       Date:  2021-08-17       Impact factor: 3.734

7.  Depression care and treatment in a chronically ill Medicare population.

Authors:  Hsiang Huang; Joan Russo; Amy M Bauer; Ya-Fen Chan; Wayne Katon; Diane Hogan; Jürgen Unützer
Journal:  Gen Hosp Psychiatry       Date:  2013-04-01       Impact factor: 3.238

8.  Care pathways for people with major depressive disorder: a European Brain Council Value of Treatment study.

Authors:  Rebecca Strawbridge; Paul McCrone; Andrea Ulrichsen; Roland Zahn; Jonas Eberhard; Danuta Wasserman; Paolo Brambilla; Giandomenico Schiena; Ulrich Hegerl; Judit Balazs; Jose Caldas de Almeida; Ana Antunes; Spyridon Baltzis; Vladimir Carli; Vinciane Quoidbach; Patrice Boyer; Allan H Young
Journal:  Eur Psychiatry       Date:  2022-06-15       Impact factor: 7.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.